Now Feluda to detect Covid cases : Tata Group to launch India's CRISPR Covid Test

▴ Now Feluda to detect Covid cases : Tata Group to launch India's CRISPR Covid Test
FELUDA is actually an acronym - FNACS9 Editor Linked Uniform Detection Assay (FELUDA) – for an indigenous test for rapid diagnosis of Covid-19.

India’s first COVID-19 detecting paper strip ‘Feluda’ delivers results within minutes! One of the most pertinent questions going on in everyone’s head is if they are infected with Coronavirus but have no symptoms? In a matter of minutes, courtesy writer and film-maker Satyajit Ray’s popular fictional detective, ‘Feluda,’ could now clear all your doubts. The ‘Feluda’ is a paper-based test strip that detects the latest coronavirus in an hour, and can now be the solution to the urgent need for rapid testing in India, a LiveMint report indicates.

A team led by two scientists of Bengali descent, Dr. Souvik Maiti and Dr. Debojyoti Chakraborty, at the Institute of Genomics and Integrative Biology (CSIR-IGIB) of the Council of Science & Industrial Research in New Delhi, have come up with a simple strip-test to tell you if you have COVID-19 in minutes, a New18 report has stated. The study uses the state-of-the-art gene-editing tool-Crispr-Cas9 to target and identifies genomic sequences of the novel coronavirus in suspected individual samples.

The kit is similar to a compact paper-strip test used to confirm pregnancy and is much less complex and needs no specific professional expertise to perform. The team led by Dr Souvik Maiti and Dr Debjyoti Chakraborty is currently testing the package in a patient population for its accuracy and responsiveness and hopes to obtain approval within a week from an Indian Medical Research Council (ICMR) regulatory body.

Unlike the real-time PCR test currently being used for Covid-19 diagnosis in India, which costs about 4500, the paper-strip test costs less than 500. It also does not rely on expensive real-time PCR machines for RNA isolation, DNA conversion, and amplification which are already in limited supply, the News18 report indicated.

Although this method has been tested by scientists in other countries including Stanford University and the Massachusetts Institute of Technology (MIT), it is the first such indigenous test kit to be developed in India based on CRISPR technology.

This testing method can be a boon for India where lockdown is about to end and people will have to come back to work. The ability to know if they have Coronavirus infection or not will help firms and employees in decision making over the resumption of coming to the office for work.

Tags : #FeludaCovidTest #FNACS9EditorLinkedUniformDetectionAssay #StanfordUniversity #MIT #MadeInIndiaCovidTest #LatestCovidNewsUpdateSep21 #LatestCovidTestingNewsUpdateSep21

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024
Kamineni Doctors Successfully Remove Bone Stuck Near Heart in Elderly PatientMay 14, 2024
On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology NursesMay 14, 2024